S
0.028
0.00 (-10.26%)
| Previous Close | 0.031 |
| Open | 0.031 |
| Volume | 104,984 |
| Avg. Volume (3M) | 22,709,978 |
| Market Cap | 908,614 |
| Price / Sales | 3.05 |
| Price / Book | 10.65 |
| 52 Weeks Range | |
| Earnings Date | 12 May 2025 - 16 May 2025 |
| Operating Margin (TTM) | -28,891.71% |
| Diluted EPS (TTM) | -3.07 |
| Current Ratio (MRQ) | 2.25 |
| Operating Cash Flow (TTM) | -100.02 M |
| Levered Free Cash Flow (TTM) | -57.94 M |
| Return on Assets (TTM) | -59.88% |
| Return on Equity (TTM) | -776.96% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Bearish |
| Biotechnology (Global) | Mixed | Bearish | |
| Stock | Syros Pharmaceuticals, Inc. | Mixed | Bearish |
AIStockmoo Score
0.3
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 5.0 |
| Technical Oscillators | -2.0 |
| Average | 0.33 |
|
Syros Pharmaceuticals Inc is a biopharmaceutical company committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Value |
| % Held by Insiders | 0.76% |
| % Held by Institutions | 33.98% |
No data within this time range.
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 28 Feb 2025 | Announcement | Syros Announces Voluntary Delisting from Nasdaq and SEC Deregistration |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |